Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.
about
Terlipressin for hepatorenal syndromeRenal failure in cirrhosis: Emerging conceptsCreatinine Change on Vasoconstrictors as Mortality Surrogate in Hepatorenal Syndrome: Systematic Review & Meta-AnalysisPhysiology of kidney reninProtecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Idiopathic cerebrospinal fluid overproduction: case-based review of the pathophysiological mechanism implied in the cerebrospinal fluid productionVasopressin in septic shock: effects on pancreatic, renal, and hepatic blood flow.Prevention of acute renal failure in the critically ill.Current management of the complications of portal hypertension: variceal bleeding and ascites.Therapy insight: Management of hepatorenal syndrome.Pharmacology, clinical efficacy and safety of terlipressin in esophageal varices bleeding, septic shock and hepatorenal syndrome.Management of refractory ascites and hepatorenal syndrome.Review article: albumin in the treatment of liver diseases--new features of a classical treatment.Review article: albumin for circulatory support in patients with cirrhosis.Therapeutic response to vasoconstrictors in hepatorenal syndrome parallels increase in mean arterial pressure: a pooled analysis of clinical trials.Albumin treatment regimen for type 1 hepatorenal syndrome: a dose-response meta-analysis.Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?Review article: hepatorenal syndrome--how to assess response to treatment and nonpharmacological therapy.Review article: pharmacological treatment of hepatorenal syndrome.Reconsidering hepatorenal syndrome. Throw in the towel? Not so fast!Hepatorenal syndrome: a dreaded complication of end-stage liver disease.Review article: current management of renal dysfunction in the cirrhotic patient.Hepatorenal syndrome: the 8th International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group.Variceal bleeding: pharmacological therapy.Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome.Renal dysfunction in liver cirrhosis.Albumin regeneration in liver support-comparison of different methods.Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis.Meta-analysis: terlipressin therapy for the hepatorenal syndrome.Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.Hyponatremia and Hepatorenal SyndromePredictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics.A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndromeThe management of renal failure in patients with liver disease. Experiences from a district general hospital.Acute kidney injury in cirrhosis.Updates on Hepato-Renal SyndromePoor outcomes with treatment of hepatorenal syndrome type 1 with splanchnic vasoconstrictors and albumin: report of seven cases and review of the literature.Clinical use of albumin in hepatology.Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials.
P2860
Q24243962-44C166A8-EEE5-4F9C-BF28-689D5E511580Q26785971-3DAFE7C2-EC32-4B22-A28A-4D7366FB1ECDQ26795734-605CC051-B4B2-4254-8AF7-BD840E4AAF7FQ28279771-0DD57D64-1B81-463E-8B7C-6D87EEBE8395Q30251763-B06CB192-5007-4F66-B37B-1BDFB8EA7DD0Q30845487-AF455BD5-5FF3-43B1-9EA4-81016EA747B4Q33310207-851F2E56-A435-4554-B090-93B399CF5EE2Q34511403-52DE090E-41DB-4CD7-BB2D-09666DD5C609Q34523099-85ABFE9A-145E-4B61-9395-C973EB15D3FAQ34533221-241EE52A-2A14-4B13-BCE6-0FEE5E1DD1E9Q34601701-467691DC-B012-420C-B183-6B127CE14872Q34619402-B06A1BBC-1EED-436A-9BA0-FD283662B392Q34992519-FADA1732-C378-4E5C-99AC-81BD7DAC4B7BQ34992534-7E0B9AF6-7EC4-465F-B632-808004924B7AQ35654104-42D0CA0A-8A0A-4C9E-9CCF-8E4A5066FD34Q35852815-D50DA1AE-949D-49C1-AA08-B51414775B75Q35873829-CEDBB2F0-9A5E-455D-A669-18A8C77E2625Q35873836-C0535FD5-9D9F-453B-B4B3-19BB8E69A76FQ35873840-1553E0C0-80AE-42AA-A4D4-AF1F39EBC067Q35994071-5522FDAE-D1C8-48A0-B4E9-A33D74BDAA0AQ36018527-79EDDE86-85C0-4710-A26A-F7A1232D9587Q36090748-9F0622D8-E231-42FF-900D-1146E10D52B7Q36093575-B117E1A2-FCFF-421C-B060-FFE05D221820Q36141427-65D6F333-E7D7-4DD2-BE14-4AD3AA5669DCQ36203618-1D644436-0241-4B51-8064-AA68DDAE0FCBQ36369769-E6A8B0E2-C817-440A-AD12-14E008EA8FECQ36473219-346B199B-9C75-481E-BAC5-C03444D6D265Q36510687-D3993BC2-F24D-4BC4-A234-759F3B395D13Q36583826-C3A868F5-83E6-4717-BF5B-56F4EF162E74Q36642098-B89C991F-B0EA-4685-A47A-F2E65F3651CCQ36772257-99072235-95E4-4F60-9514-315BC9BB54DFQ36812531-8C69F03B-4355-4684-866C-CB4E3852C3A2Q37058079-22548407-0D70-45EA-83E8-700548D52985Q37061659-28216320-74DE-4694-97CA-9CBEBA5A0170Q37141944-57373CA3-5B6F-49AD-9149-F7C7BD39ED4BQ37323711-D79CB2F0-321A-4F0B-AFB7-66E144ECCFFAQ37498513-58D0CAD0-FD70-490F-939F-6F5717EE3D86Q37634026-D3BAE759-4FA6-4103-9BD5-A194677382F6Q37655017-40B4DD6F-FF42-46F0-AE25-38E9EC90D905Q37674956-EC21EDFB-2D68-4B85-95E4-8FE737430773
P2860
Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Terlipressin plus albumin infu ...... erapy of hepatorenal syndrome.
@ast
Terlipressin plus albumin infu ...... erapy of hepatorenal syndrome.
@en
type
label
Terlipressin plus albumin infu ...... erapy of hepatorenal syndrome.
@ast
Terlipressin plus albumin infu ...... erapy of hepatorenal syndrome.
@en
prefLabel
Terlipressin plus albumin infu ...... erapy of hepatorenal syndrome.
@ast
Terlipressin plus albumin infu ...... erapy of hepatorenal syndrome.
@en
P2093
P1476
Terlipressin plus albumin infu ...... erapy of hepatorenal syndrome.
@en
P2093
Bataller R
Cárdenas A
Salmerón JM
P356
10.1016/S0168-8278(00)80158-0
P577
2000-07-01T00:00:00Z